Matheis Dennis 的 Form 4/A 修正申報
修正Lucid Diagnostics Inc.（LUCD），2025/5/23 申報
- 申報編號
- 0001062993-25-010245
- 申報時間
- 2025/5/23
- 交易日
- 2025/5/20-5/22
- 申報延遲
- 3 天
- 10b5-1 計畫
- 沒有勾選
- 原始申報日
- 2025/5/22
這份申報列了 3 筆非衍生性交易。公開市場買進合計 $45.8 萬。交易後 3 天申報。
這份修正申報取代了 0001062993-25-010111（2025/5/22 申報）。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Matheis DennisCIK 0001817012 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $1.265 to $1.30. inclusive. The reporting person undertakes to provide to Lucid Diagnostics Inc., any security holder of Lucid Diagnostics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form4.
表 I 有 1 筆交易的價格引用這則附註。
- F2
The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $1.315 to $1.32, inclusive.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $1.305 to $1.32, inclusive.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Includes 52,718 shares of Lucid common stock distributed on a pro rata basis to the reporting person by a limited partnership of which the reporting person is a limited partner.
備註
The reporting person is filing this amendment to the Form 4 initially filed on May 22, 2025 solely to correct the number of shares beneficially owned by the reporting person following the reported transactions. The initial filing omitted from this amount 215,443 shares (which includes the 52,718 shares referenced in footnote 4) held by the reporting person prior to the reported transactions.